Introducing the Rosalind Academic Plan, offering eligible labs sponsored access to GPT‑Rosalind and tools for life sciences discovery.

We’re introducing the Rosalind Academic Plan to help more academic scientists access GPT‑Rosalind⁠, our dedicated life sciences model, which combines frontier reasoning with Rosalind workbench⁠(opens in a new window) that enables specialized tool orchestration across medicinal chemistry, genomics, wet-lab assistance, and other scientific applications. Eligible labs can receive up to 30 Business Standard seats at no cost for up to 12 months, with access to GPT‑Rosalind subject to trusted-access approval.

Academic research creates knowledge that entire fields build on. Work that begins with a fundamental question about biology can eventually change how we diagnose disease, develop medicines, or grow food. But those advances depend on scientists having the resources to explore ideas, test them, and share what they learn.

Accelerating scientific discovery is central to OpenAI’s mission of ensuring that artificial general intelligence benefits all of humanity. With this plan, we’re investing in the scientists doing that foundational work—helping more labs combine their expertise and judgment with AI tools built for life sciences research.

Many of the advances we rely on today grew out of years of basic research.

The Human Genome Project helped launch modern genomics, transforming medicine, diagnostics, and biotechnology.

Curiosity-driven work on bacterial immune systems led to CRISPR-Cas9, which revolutionized genome editing and is now advancing research in cancer, inherited disease, agriculture, and biotechnology. Decades of university research on mRNA also laid the groundwork for COVID-19 vaccines and a new generation of vaccines and therapies.

Source link